Hemangiomas revisited: the useful, the unusual and the new (original) (raw)
Related papers
Infantile Hemangiomas: An Update on Pathogenesis and Treatment
Journal of Clinical Medicine
Infantile hemangiomas are the most common benign vascular tumors in infancy. This review includes an update on the current knowledge on pathogenesis, a discussion on indications for treatment, and a review of the mechanisms underlying the different treatment methods. Although most infantile hemangiomas require only active observation because of their natural course, which results in involution, about 10% present with complications that require immediate treatment. The basic treatment includes systemic and topical options. In cases of insufficient response or rebound growth, other forms of treatment should be considered. In some cases, combined therapy might be initiated.
F1000Research, 2019
Hemangiomas are common benign vascular tumors that often present in childhood. Diagnosis is based on clinical history, physical examination, and, when unclear, assisted with ultrasound or MRI. While the majority are small, nonproblematic, and can be managed conservatively, some hemangiomas may be associated with underlying syndromes or concerning for visceral involvement. Symptomatic lesions may develop ulceration, bleeding, vision disturbances, functional limitations, or disfigurement. The ideal treatment for a symptomatic hemangioma is often multimodal and may vary depending on the size, location, and proximity to critical structures. Medical treatments include topical beta blockers, oral propranolol, or steroid injections. Surgical resection and laser therapies may be necessary to optimize long term outcomes.
Journal of Oral and Maxillofacial Pathology, 2011
Hemangiomas occupy a grey zone between hamartomatous malformations and true neoplasms. They are frequently designated and regarded as neoplasms because of their usually localized nature and mass effect. Although clearly benign, they can become very large and unsightly, and can even be fatal if they affect vital structures. They almost never become malignant, although a few documented examples of this complication are on record. A high percentage occur in children, manifesting within the first month of life. One half of these cases are in the head and neck area. Hemangiomas have been classified according to their clinical appearance and the caliber of vessel involved, namely, capillary, cavernous and venous. Capillary hemangiomas are made up of small vessels of capillary caliber. One such capillary hemangioma, the juvenile hemangioma (JH), is usually present at birth or appears during the first month and enlarges rapidly during the first few months of life (infancy), only to stop growing when the child is approximately 6 years old. We present one such JH, seen in a 3 year old male child, which appeared when the child was 2 months old. Routine histopathological (H and E) and immunohistochemical analysis (CD 34, CD 31) was done on biopsy received.
A Case Report on Infantile Hemangioma
https://www.ijhsr.org/IJHSR\_Vol.8\_Issue.11\_Nov2018/IJHSR\_Abstract.045.html, 2018
Infantile hemangiomas are vascular tumors of infancy and early childhood age with approximately 5-10% prevalence rate among infants. Hemangiomas are formed by overly proliferated capillaries which are packed densely, which contains high density of cells in which open lumens are absent. The tumor is highly proliferative by nature during infancy. Hemangiomas stabilizes subsequently with time and tumor undergo slow and spontaneous involution, most of which regresses completely by 5 years of age. In females patients its prevalence is 3 times more in comparison to male patient. So, we have reported and presenting a case report of a female child of 4 months old reported to us with swelling on left side of face. No birth mark was present at her birth but with passage of time swelling appeared and increased in size progressively, with a tendency of easy bleed even with minor injuries and the regression of the lesion suggests a case of infantile hemangioma.
1995
The typical appearance of cutaneous hemangiomas of infancy is well known. We studied unusual manifestations of this common tumor. We reviewed over SOO hemangiomas in the registry of the Vascuiar Anomaiies Program at Boston Chiidren's Hospitai. We found four uncommon morphologic variations: deep hemangiomas with normal overlying skin {n = 12); macular hemangiomas with a port-wine stainiike appearance (n = 6); bossed hemangiomas with telangiectasia and peripheral pallor (n = 5); and hemangiomas with persistent fast flow (n = 3). Deep and superftciai (macular) varieties regressed at a normal rate. Telangiectatic (bossed) hemangiomas, however, involuted rapidly, usually before 1 year of age. Hemangiomas with persistent fast flow required either resection or sclerotherapy for complications in eariy childhood.
The Profiles of Infantile Hemangiomas Patients
Berkala Ilmu Kesehatan Kulit dan Kelamin
Background: Infantile hemangiomas (IH) are the most prevalent benign tumors in children, predominantly in girls. Most IH cases do not require treatment due to spontaneous involution, but 10% of cases do require early treatment due to size, location, and complications. Purpose: This study tried to define the profile, clinical aspects, and therapy of IH in Dr. Zainoel Abidin General Hospital, Banda Aceh. Methods: A descriptive approach using a retrospective analysis employing secondary data from the outpatient clinic's patient registration book. This study included all new cases of infantile hemangioma at the outpatient clinic general hospital between 2013 and 2021. Result: A total of 105 patients were involved in this study. The majority of IH patients (59%) were under the age of one year, with 64 female patients (61%) making the most visits to the pediatric clinic in 2017, 2018, and 2019 (77.1%). The most prevalent clinical features of skin lesions were nodules in 69 individuals...
Infantile hemangioma: a brief review
Clujul Medical, 2015
physiopathology is yet to be fully understood. Numerous publications outline the characteristics, causes, evolution possibilities and therapeutic approaches. Deciding whether to treat or not is the main question of this kind of pathology. Hemangiomas that have complications or can cause irreversible damage need therapy. This is a brief review of up-to-date information regarding the presentation of infantile hemangiomas and target-therapies.